Activation of the cAMP pathway synergistically increases IL-1-induced IL-6 gene expression in FRTL-5 thyroid cells: Involvement of AP-1 transcription factors

Molecular and Cellular Endocrinology

Volumn 284, Issue 1-2, 2008, Pages 28-37

  Szabo Fresnais, Nicolas ^a,b   Blondeau, Jean Paul ^a,c   Pomérance, Martine ^a,b  

^a INSERM   (France)

^b Universite Paris Sud   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

AP 1; cAMP; IL 1; IL 6; Stabilization; Thyroid cell

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; INTERLEUKIN 1; INTERLEUKIN 6; MESSENGER RNA; PROTEIN C FOS; THYROTROPIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FRA 2;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL INFILTRATION; CELL TYPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GENE DELETION; GENE EXPRESSION; GRAVES DISEASE; HASHIMOTO DISEASE; HORMONAL REGULATION; IMMUNOCOMPETENT CELL; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; THYROID CELL;

EID: 39649109059     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2007.12.017     Document Type: Article

References (43)

1. Akira S., Isshiki H., Sugita T., Tanabe O., Kinoshita S., Nishio Y., Nakajima T., Hirano T., and Kishimoto T. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 9 (1990) 1897-1906
2. Aust G., and Scherbaum W.A. Expression of cytokines in the thyroid: thyrocytes as potential cytokine producers. Exp. Clin. Endocrinol. Diabetes 104 Suppl. 4 (1996) 64-67
3. Correze C., Blondeau J.P., and Pomerance M. The thyrotropin receptor is not involved in the activation of p42/p44 mitogen-activated protein kinases by thyrotropin preparations in Chinese hamster ovary cells expressing the human thyrotropin receptor. Thyroid 10 (2000) 747-752
4. Correze C., Blondeau J.P., and Pomerance M. p38 mitogen-activated protein kinase contributes to cell cycle regulation by cAMP in FRTL-5 thyroid cells. Eur. J. Endocrinol. 153 (2005) 123-133
5. de Rooij J., Zwartkruis F.J., Verheijen M.H., Cool R.H., Nijman S.M., Wittinghofer A., and Bos J.L. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396 (1998) 474-477
6. Deleu S., Pirson I., Clermont F., Nakamura T., Dumont J.E., and Maenhaut C. Immediate early gene expression in dog thyrocytes in response to growth, proliferation, and differentiation stimuli. J. Cell. Physiol. 181 (1999) 342-354
7. Dendorfer U., Oettgen P., and Libermann T.A. Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Mol. Cell. Biol. 14 (1994) 4443-4454
8. Dhakras P.S., Hajarnis S., Taylor L., and Curthoys N.P. cAMP-dependent stabilization of phosphoenolpyruvate carboxykinase mRNA in LLC-PK1-F+ kidney cells. Am. J. Physiol. Renal Physiol. 290 (2006) F313-F318
9. Diamant M., Kayser L., Rasmussen A.K., Bech K., and Feldt-Rassmussen U. Interleukin-6 production by thyroid epithelial cells. Enhancement by interleukin-1. Autoimmunity 11 (1991) 21-26
10. Elias J.A., and Lentz V. IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA. J. Immunol. 145 (1990) 161-166
11. Grassl C., Luckow B., Schlondorff D., and Dendorfer U. Transcriptional regulation of the interleukin-6 gene in mesangial cells. J. Am. Soc. Nephrol. 10 (1999) 1466-1477
12. Grubeck-Loebenstein B., Buchan G., Chantry D., Kassal H., Londei M., Pirich K., Barrett K., Turner M., Waldhausl W., and Feldmann M. Analysis of intrathyroidal cytokine production in thyroid autoimmune disease: thyroid follicular cells produce interleukin-1 alpha and interleukin-6. Clin. Exp. Immunol. 77 (1989) 324-330
13. Hershko D.D., Robb B.W., Luo G., and Hasselgren P.O. Multiple transcription factors regulating the IL-6 gene are activated by cAMP in cultured Caco-2 cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283 (2002) R1140-R1148
14. Hirano T., Akira S., Taga T., and Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol. Today 11 (1990) 443-449
15. Isozaki O., and Kohn L.D. Control of c-fos and c-myc proto-oncogene induction in rat thyroid cells in culture. Mol. Endocrinol. 1 (1987) 839-848
16. Iwamoto M., Sakihama T., Kimura N., Tasaka K., and Onaya T. Augmented interleukin 6 production by rat thyrocytes (FRTL5): effect of interleukin 1 beta and thyroid-stimulating hormone. Cytokine 3 (1991) 345-349
17. Kennedy R.L., Jones T.H., Davies R., Justice S.K., and Lemoine N.R. Release of interleukin-6 by human thyroid epithelial cells immortalized by simian virus 40 DNA transfection. J. Endocrinol. 133 (1992) 477-482
18. Kikumori T., Kambe F., Nagaya T., Funahashi H., and Seo H. Thyrotropin modifies activation of nuclear factor kappaB by tumour necrosis factor alpha in rat thyroid cell line. Biochem. J. 354 (2001) 573-579
19. Kishimoto T. Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res. Ther. 8 Suppl. 2 (2006) S2
20. Libermann T.A., and Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol. Cell. Biol. 10 (1990) 2327-2334
21. Mahtani K.R., Brook M., Dean J.L., Sully G., Saklatvala J., and Clark A.R. Mitogen-activated protein kinase p38 controls the expression and post-translational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability. Mol. Cell. Biol. 21 (2001) 6461-6469
22. McCall K.D., Harii N., Lewis C.J., Malgor R., Kim W.B., Saji M., Kohn A.D., Moon R.T., and Kohn L.D. High basal levels of functional toll-like receptor 3 (TLR3) and non-cannonical Wnt5a Are expressed in papillary thyroid cancer (PTC) and are coordinately decreased by phenylmethimazole together with cell proliferation and migration. Endocrinology 148 (2007) 4226-4237
23. Miyazawa K., Mori A., Miyata H., Akahane M., Ajisawa Y., and Okudaira H. Regulation of interleukin-1beta-induced interleukin-6 gene expression in human fibroblast-like synoviocytes by p38 mitogen-activated protein kinase. J. Biol. Chem. 273 (1998) 24832-24838
24. Neininger A., Kontoyiannis D., Kotlyarov A., Winzen R., Eckert R., Volk H.D., Holtmann H., Kollias G., and Gaestel M. MK2 targets AU-rich elements and regulates biosynthesis of tumor necrosis factor and interleukin-6 independently at different post-transcriptional levels. J. Biol. Chem. 277 (2002) 3065-3068
25. Northemann W., Braciak T.A., Hattori M., Lee F., and Fey G.H. Structure of the rat interleukin 6 gene and its expression in macrophage-derived cells. J. Biol. Chem. 264 (1989) 16072-16082
26. Pasare C., and Medzhitov R. Toll pathway-dependent blockade of CD4 + CD25 + T cell-mediated suppression by dendritic cells. Science 299 (2003) 1033-1036
27. Pirson I., Coulonval K., Lamy F., and Dumont J.E. c-Myc expression is controlled by the mitogenic cAMP-cascade in thyrocytes. J. Cell. Physiol. 168 (1996) 59-70
28. Pomerance M., Carapau D., Chantoux F., Mockey M., Correze C., Francon J., and Blondeau J.P. CCAAT/enhancer-binding protein-homologous protein expression and transcriptional activity are regulated by 3′,5′-cyclic adenosine monophosphate in thyroid cells. Mol. Endocrinol. 17 (2003) 2283-2294
29. Pomerance M., Thang M.N., Tocque B., and Pierre M. The Ras-GTPase-activating protein SH3 domain is required for Cdc2 activation and mos induction by oncogenic Ras in Xenopus oocytes independently of mitogen-activated protein kinase activation. Mol. Cell. Biol. 16 (1996) 3179-3186
30. Ruggeri R.M., Barresi G., Sciacchitano S., Trimarchi F., Benvenga S., and Trovato M. Immunoexpression of the CD30 ligand/CD30 and IL-6/IL-6R signals in thyroid autoimmune diseases. Histol. Histopathol. 21 (2006) 249-256
31. Shim J., and Karin M. The control of mRNA stability in response to extracellular stimuli. Mol. Cells 14 (2002) 323-331
32. Simons P.J., Delemarre F.G., and Drexhage H.A. Antigen-presenting dendritic cells as regulators of the growth of thyrocytes: a role of interleukin-1beta and interleukin-6. Endocrinology 139 (1998) 3148-3156
33. Simons P.J., Delemarre F.G., Jeucken P.H., and Drexhage H.A. Pre-autoimmune thyroid abnormalities in the biobreeding diabetes-prone (BB-DP) rat: a possible relation with the intrathyroid accumulation of dendritic cells and the initiation of the thyroid autoimmune response. J. Endocrinol. 157 (1998) 43-51
34. Tan K.S., Nackley A.G., Satterfield K., Maixner W., Diatchenko L., and Flood P.M. Beta2 adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA- and NF-kappaB-independent mechanisms. Cell. Signal. 19 (2007) 251-260
35. Tanabe O., Akira S., Kamiya T., Wong G.G., Hirano T., and Kishimoto T. Genomic structure of the murine IL-6 gene. High degree conservation of potential regulatory sequences between mouse and human. J. Immunol. 141 (1988) 3875-3881
36. Todd I., Pujol-Borrell R., Hammond L.J., McNally J.M., Feldmann M., and Bottazzo G.F. Enhancement of thyrocyte HLA class II expression by thyroid stimulating hormone. Clin. Exp. Immunol. 69 (1987) 524-531
37. Tramontano D., Chin W.W., Moses A.C., and Ingbar S.H. Thyrotropin and dibutyryl cyclic AMP increase levels of c-myc and c-fos mRNAs in cultured rat thyroid cells. J. Biol. Chem. 261 (1986) 3919-3922
38. Trovato M., Grosso M., Vitarelli E., Ruggeri R.M., Alesci S., Trimarchi F., Barresi G., and Benvenga S. Distinctive expression of STAT3 in papillary thyroid carcinomas and a subset of follicular adenomas. Histol. Histopathol. 18 (2003) 393-399
39. Vanden Berghe W., Plaisance S., Boone E., De Bosscher K., Schmitz M.L., Fiers W., and Haegeman G. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J. Biol. Chem. 273 (1998) 3285-3290
40. Vanden Berghe W., Vermeulen L., De Wilde G., De Bosscher K., Boone E., and Haegeman G. Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6. Biochem. Pharmacol. 60 (2000) 1185-1195
41. Weetman A.P., and McGregor A.M. Autoimmune thyroid disease: further developments in our understanding. Endocrinol. Rev. 15 (1994) 788-830
42. Weetman A.P., Bright-Thomas R., and Freeman M. Regulation of interleukin-6 release by human thyrocytes. J. Endocrinol. 127 (1990) 357-361
43. Winzen R., Kracht M., Ritter B., Wilhelm A., Chen C.Y., Shyu A.B., Muller M., Gaestel M., Resch K., and Holtmann H. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism. EMBO J. 18 (1999) 4969-4980